Tenet Healthcare Corp. (THC) Misses Q4 EPS by 4c; Raises FY12 EBITDA Outlook
Tenet Healthcare Corp. (NYSE: THC) reported Q4 EPS of $0.10, $0.04 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $2.23 billion versus the consensus estimate of $2.4 billion.
Raised its FY12 adj-EBITDA guidance from $1.2-$1.3 billion to $1.225-$1.35 billion.
For earnings history and earnings-related data on Tenet Healthcare Corp. (THC) click here.
Raised its FY12 adj-EBITDA guidance from $1.2-$1.3 billion to $1.225-$1.35 billion.
For earnings history and earnings-related data on Tenet Healthcare Corp. (THC) click here.